A new drug candidate for hard-to-treat cancers NXP900, discovered at the University of Edinburgh and licensed by biopharmaceutical company Nuvectis Pharma, Inc., has received US Food and Drug Administration (FDA) clearance to proceed to clinical trials.
Ovarian cancer therapy boosted by drug that could cut chance of dying – study jerseyeveningpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jerseyeveningpost.com Daily Mail and Mail on Sunday newspapers.
A new study suggests a drug used to treat skin and lung cancers could also cut the chance of dying from a type of ovarian cancer. The drug – called tramet.